Cargando…
The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial
The aim of this clinical trial was to control the cytokine storm by administering mesenchymal stem cells (MSCs) to critically-ill COVID-19 patients, to evaluate the healing effect, and to systematically investigate how the treatment works. Patients with moderate and critical COVID-19 clinical manife...
Autores principales: | Adas, G, Cukurova, Z, Yasar, K Kart, Yilmaz, R, Isiksacan, N, Kasapoglu, P, Yesilbag, Z, Koyuncu, ID, Karaoz, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243094/ https://www.ncbi.nlm.nih.gov/pubmed/34180719 http://dx.doi.org/10.1177/09636897211024942 |
Ejemplares similares
-
The Effect of Host miRNAs on Prognosis in COVID-19: miRNA-155 May Promote Severity via Targeting Suppressor of Cytokine Signaling 1 (SOCS1) Gene
por: Gedikbasi, Asuman, et al.
Publicado: (2022) -
Wharton’s Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study
por: Kabataş, Serdar, et al.
Publicado: (2018) -
Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids
por: Hindilerden, Fehmi, et al.
Publicado: (2020) -
Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
por: Irmak, Duygu Koyuncu, et al.
Publicado: (2020) -
The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study
por: Erdal, Gulcin Sahingoz, et al.
Publicado: (2021)